50474-983-86 : NDC 2026 Code

50474-983-86 : Rozanolixizumab ( Rystiggo )

Additionally :

You can get information about “50474-983-86” NDC code in 50474-983-86 in HTML format

HTML | 50474-983-86 in TXT (Plain Text) format

TXT | 50474-983-86 in PDF (Portable Document Format)

PDF | 50474-983-86 in XML format

XML formats.

NDC Code : 50474-983-86 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "50474-983-86",
    "PackageDescription": "1 VIAL, GLASS in 1 CARTON (50474-983-86)  / 6 mL in 1 VIAL, GLASS",
    "NDC11Code": "50474-0983-86",
    "ProductNDC": "50474-983",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Rystiggo",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Rozanolixizumab",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "SUBCUTANEOUS",
    "StartMarketingDate": "20240614",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761286",
    "LabelerName": "UCB, Inc.",
    "SubstanceName": "ROZANOLIXIZUMAB",
    "StrengthNumber": "140",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Neonatal Fc Receptor Blocker [EPC], Neonatal Fc Receptor Blockers [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-01-22",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20240715",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}